📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

EAACI Biologicals Guidelines-dupilumab for children and adults with moderate-to-severe atopic dermatitis. (2021)

First Author: Agache I

Attributed to: Cutaneous Immunology funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/all.14690

PubMed Identifier: 33538044

Publication URI: http://europepmc.org/abstract/MED/33538044

Type: Journal Article/Review

Volume: 76

Parent Publication: Allergy

Issue: 4

ISSN: 0105-4538